Join BIOCYTOGEN at Society for Neuroscience Annual Meeting
We’re proud to announce that we’ll be exhibiting at the Society for Neuroscience Annual Meeting 2024 in Chicago, October 6th to 9th! This renowned event brings together basic and clinical scientists to exchange ideas and explore innovations in biotechnology. Come meet us and engage with industry leaders at the forefront of scientific discovery.
What is the Society for Neuroscience Annual Meeting?
The Society for Neuroscience annual meeting gathering over 25,000 industry leaders, researchers, investors, and entrepreneurs from the global biotechnology sector is filled with exciting talks, interactive panel discussions, and networking opportunities. This conference provides an exciting glimpse into the most innovative work happening in neuroscience, packed into one dynamic week. From pioneering research presentations to thought-provoking panel discussions, we’ve designed a program that highlights the diverse and groundbreaking advancements shaping our field.
Event Overview
Date: October 5th-9th 9:00am-5:00pm
Venue: McCormick Place Convention Center, 2301 S Martin Luther King Dr, Chicago, IL 60616
Event Schedule
The Society for Neuroscience Annual Meeting in Chicago will showcase a diverse array of speakers and topics. For a comprehensive look at the daily schedule, including session times and detailed information on each presentation, please refer to the Society for Neuroscience Annual Meeting agenda.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you at the Society for Neuroscience Annual Meeting 2024 in Chicago! Don’t forget to stop by Booth #181 from Oct 6-9 for Biomice stickers, lab luck, and some awesome neuroscience chats!
